69 related articles for article (PubMed ID: 1481145)
1. [The new antihypertensive preparation guanfacine (Estulic)].
Eliseev OM
Ter Arkh; 1992; 64(9):103-12. PubMed ID: 1481145
[No Abstract] [Full Text] [Related]
2. Estulic--a well tolerated and effective antihypertensive drug in general practice.
Török K
Ther Hung; 1992; 40(2):79-82. PubMed ID: 1462281
[TBL] [Abstract][Full Text] [Related]
3. Estulic monotherapy and combined antihypertensive therapy.
Faluhelyi A; Szentkereszty A
Ther Hung; 1991; 39(2):87-9. PubMed ID: 1948783
[TBL] [Abstract][Full Text] [Related]
4. [Guanfacine in the treatment of arterial hypertension in diabetics].
Monova D; Daskalova I; Belovezhdov N
Vutr Boles; 1990; 29(6):44-7. PubMed ID: 2091382
[TBL] [Abstract][Full Text] [Related]
5. [Estulic (guanfacine) in the treatment of arterial hypertension].
Erina EV; Beliakova EV; Charyev KhE
Ter Arkh; 1992; 64(8):36-9. PubMed ID: 1440392
[No Abstract] [Full Text] [Related]
6. [The treatment of hypertension patients with Estulic].
Baliakina EV; Anuchin VV; Patrusheva IF; Iurenev AP
Ter Arkh; 1996; 68(12):57-60. PubMed ID: 9054043
[TBL] [Abstract][Full Text] [Related]
7. Small and large doses of guanfacine (Estulic Sandoz) in the treatment of hypertension.
Mayer O; Polívková H
Cor Vasa; 1987; 29(4 Suppl 1):37-41. PubMed ID: 3315449
[TBL] [Abstract][Full Text] [Related]
8. The effect of small doses of guanfacine (Estulic Sandoz) on the lipid levels and catecholamine excretion in patients with essential hypertension.
Balazovjech I; Skultétyová D; Mikulecký M; Kratochvíl'ová H
Cor Vasa; 1987; 29(4 Suppl 1):46-52. PubMed ID: 3315451
[TBL] [Abstract][Full Text] [Related]
9. Improved exercise performance of hypertensive patients treated with guanfacine (Estulic Sandoz).
Bazika V
Cor Vasa; 1987; 29(4 Suppl 1):42-5. PubMed ID: 3315450
[TBL] [Abstract][Full Text] [Related]
10. [Use of estulic in patients with arterial hypertension].
Kukes VG; Spasskiĭ AV; Alkhazov AI; Rudakov AG; Zisel'man SB
Sov Med; 1985; (12):57-61. PubMed ID: 3913006
[No Abstract] [Full Text] [Related]
11. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
Malini PL; Strocchi E; Ambrosioni E; Magnani B
Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
[TBL] [Abstract][Full Text] [Related]
12. Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
Dvorák I; Podrouzková B; Kocourková J; Kubesová H; Spác J; Nĕmcová H; Blaha M
Cor Vasa; 1987; 29(4 Suppl 1):30-6. PubMed ID: 3315448
[TBL] [Abstract][Full Text] [Related]
13. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
Schäfer N; Knaup G
Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
[No Abstract] [Full Text] [Related]
14. [Hypotensive and anti-ischemic efficiency of estulic in course treatment of myocardial infarction complicated by essential hypertension].
Tepliakov AT; Braslavskaia TG; Alugishvili MZ; Karpov RS
Ter Arkh; 1999; 71(8):27-30. PubMed ID: 10515031
[TBL] [Abstract][Full Text] [Related]
15. Guanfacine: a new centrally-acting antihypertensive agent.
Beevers DG; Bloxham CA; Walker JM
Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
[TBL] [Abstract][Full Text] [Related]
16. [Estulic in the long-term treatment of hypertension].
Rhomberg F
Schweiz Med Wochenschr; 1980 Dec; 110(50):1922-4. PubMed ID: 6782668
[TBL] [Abstract][Full Text] [Related]
17. [The calcium antagonist isradipine (Lomir) in the treatment of patients with essential hypertension].
Ol'binskaia LI; Morozova TE; Vartanova OA
Ter Arkh; 1992; 64(9):98-100. PubMed ID: 1481168
[No Abstract] [Full Text] [Related]
18. [Controlled doubleblind study on dose-effect relationship of guanfacine a long-acting hypotensive guanidine derivative (author's transl)].
Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G
Arzneimittelforschung; 1980; 30(6):1005-7. PubMed ID: 6998487
[TBL] [Abstract][Full Text] [Related]
19. Renal alpha 2a/d-adrenoceptor subtype function: Wistar as compared to spontaneously hypertensive rats.
Intengan HD; Smyth DD
Br J Pharmacol; 1997 Jul; 121(5):861-6. PubMed ID: 9222541
[TBL] [Abstract][Full Text] [Related]
20. [Dipeptidyl carboxypeptidase inhibitors--a new class of antihypertensive agents].
Shvarts GIa
Farmakol Toksikol; 1984; 47(2):105-15. PubMed ID: 6370719
[No Abstract] [Full Text] [Related]
[Next] [New Search]
